On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

Listen Live Now » 1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
66° Feels Like: 66°
Wind: WSW 10 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Sunny 66°

Tonight

Clear 46°

Tomorrow

Sunny 73°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

GlaxoSmithKline lung drug Anoro approved in Europe

LONDON (Reuters) - GlaxoSmithKline said on Thursday its new inhaled lung drug, Anoro, had been approved in Europe as a treatment for chronic lung disease, boosting its respiratory franchise.

A final green light had been expected for the product, which was developed with Theravance, following a recommendation from European experts in February.

Respiratory drugs are a major business for GSK. Advair or Seretide, its market-leading lung drug, makes up a fifth of its sales, but it is already facing competition from generic versions in Europe.

Industry analysts expect Anoro to generate worldwide annual sales of about $2.65 billion by 2019, according to Thomson Reuters data.

(Reporting by Ben Hirschler; editing by Jane Baird)

Comments